http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1310268-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d50a5d08fff80f620aa6f328cd9bc85e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
filingDate | 1987-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1992-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac250cba01e2571b7ed10f1fe9817922 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02fbed4f331ebe7d4e6ec318ad1475e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c16c3732ef77bde5b5e1249f66fe6da |
publicationDate | 1992-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-1310268-C |
titleOfInvention | Transdermal fertility control system and process |
abstract | ABSTRACT TRANSDERMAL FERTILITY CONTROLLING ABSORPTION DOSAGE UNIT AND PROCESS Transdermal fertility-controlling absorption polymer matrix dosage units have been developed which comprise a backing layer, an adjoining layer of a solid polymer matrix in which minimum effective daily doses of an estrogen and a progestin are microdispersed and released for transdermal absorption. Presently preferred is use of the natural estrogen, 17-beta-estradiol, and of the progestin, levonor-gestrel. The units have a biologically acceptable adhesive polymer layer. The polymer matrix as well as the adhesive layer can have dispersed one or more skin permeation enhancers. Dosage units are provided which transdermally deliver at least minimum daily doses of the estrogen and progestin for multiple days, such as for one week. The invention also provides a process of fertility control using the novel polymer matrix dosage units for the first three weeks of consecutive menstrual cycles of the subject desiring fertility control. |
priorityDate | 1986-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.